Analysis of the underlying cellular mechanisms of anti-CD154-induced graft tolerance: The interplay of clonal anergy and immune regulation

Journal of Immunology

Volumn 175, Issue 2, 2005, Pages 771-779

  Quezada, Sergio A ^a   Bennett, Kathy ^a   Blazar, Bruce R ^b   Rudensky, Alexander Y ^c   Sakaguchi, Shimon ^d   Noelle, Randolph J ^a  

^a NORRIS COTTON CANCER CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; CELL MARKER; INTERLEUKIN 2 RECEPTOR ALPHA; T LYMPHOCYTE RECEPTOR;

ALLOIMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VIVO STUDY; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

EID: 23244459502     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.2.771     Document Type: Article

References (60)

1. Medawar, P. B. 1991. The Nobel Lectures in Immunology: the Nobel Prize for Physiology or Medicine, 1960: immunological tolerance. Scand. J. Immunol. 33: 337-344.
2. Qin, S., S. P. Cobbold, H. Pope, J. Elliott, D. Kioussis, J. Davies, and H. Waldmann. 1993. "Infectious" transplantation tolerance. Science 259: 974-977.
3. Zamoyska, R., and H. Waldmann. 1984. Allosuppression: evidence for the involvement of both "noncytotoxic" and cytotoxic T cells. Eur. J. Immunol. 14: 645-651.
4. + immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J. Exp. Med. 193: 1311-1318.
5. Hara, M., C. I. Kingsley, M. Niimi, S. Read, S. E. Turvey, A. R. Bushell, P. J. Morris, F. Powrie, and K. J. Wood. 2001. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166: 3789-3796.
6. Wood, K. I., and S. Sakaguchi. 2003. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3: 199-210.
7. + regulatory T cells contributes to skin transplant tolerance. Transplantation 76: 1375-1379.
8. Graca, L., S. P. Cobbold, and H. Waldmann. 2002. Identification of regulatory T cells in tolerated allografts. J. Exp. Med. 195: 1641-1646.
9. Zheng, X. X., A. Sanchez-Fueyo, M. Sho, C. Domenig, M. H. Sayegh, and T. B. Strom. 2003. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 19: 503-514.
10. Sayegh, M. H., E. Akalin, W. W. Hancock, M. E. Russell, C. B. Carpenter, P. S. Linsley, and L. A. Turka. 1995. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181: 1869-1879.
11. Larsen, C. P., E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tucker-Burden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381: 434-438.
12. Lenschow, D. I., Y. Zeng, I. R. Thistlethwaite, A. Montag, W. Brady, M. G. Gibson, P. S. Linsley, and J. A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA41g. Science 257: 789-792.
13. Kirk, A. D., D. M. Harlan, N. N. Armstrong, T. A. Davis, Y. Dong, G. S. Gray. X. Hong, D. Thomas, I. H. Fechner, Jr., and S. I. Knechtle. 1997. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA 94:8789-8794.
14. Kirk, A. D., L. C. Burkly, D. S. Batty, R. E. Baumgartner, I. D. Berning, K. Buchanan, J. H. Fechner, Jr., R. L. Germond, R. L. Kampen, N. B. Patterson, et al. 1999. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat. Med, 5: 686-693.
15. Larsen, C. P., D. Z. Alexander, D. Hollenbaugh, E. T. Elwood, S. C. Ritchie, A. Aruffo, R. Hendrix, and T. C. Pearson. 1996. CD40-gp39 interactions play a critical role during allograft rejection: suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 61: 4-9.
16. Akalin, E., A. Chandraker, M. E. Russell, L. A. Turka, W. W. Hancock, and M. H. Sayegh. 1996. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo. Transplantation 62: 1942-1945.
17. Judge, T. A., Z. Wu, X. G. Zheng, A. H. Sharpe, M. H. Sayegh, and L. A. Turka. 1999. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. J. Immunol. 162: 1947-1951.
18. Gao, W., G. Demirci, T. B. Strom, and X. C. Li. 2003. Stimulating PD-1-negative signals concurrent with blocking CD 154 co-stimulation induces long-term islet allograft survival. Transplantation 16: 994-999.
19. Demirci, G., F. Amanullah, R. Kewalaramani, H. Yagita, T. B. Strom, M. H. Sayegh, and X. C. Li. 2004. Critical role of OX40 in CD28 and CD154-independent rejection. J. Immunol. 172: 1691-1698.
20. Bishop, D. K., W. Li, S. Y. Chan, R. D. Ensley, I. Shelby, and E. I. Eichwald. 1994. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells: implications for cellular and humoral responses. Transplantation 58: 576-584.
21. Bishop, D. K., I. Shelby, and E. J. Eichwald. 1991. Functional analysis of donor-reactive T cells infiltrating heterotopic cardiac transplants: effect of anti-CD4 MAb in vivo. Transplant. Proc. 23: 287-289.
22. Nathan, M. I., D. Yin, E. J. Eichwald, and D. K. Bishop. 2002. The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells. Am. J. Transplant. 2: 323-332.
23. + T cells, interferon-γ, and CTLA4. J. Clin. Invest. 101: 2446-2455.
24. Rossini, A. A., D. C. Parker, N. E. Phillips, F. H. Durie, R. J. Noelle, J. P. Mordes, and D. L. Greiner. 1996. Induction of immunological tolerance to islet illografts. Cell. Transplant. 5: 49-52.
25. Markees, T. G., N. E. Phillips, R. J. Noelle, L. D. Shultz, J. P. Mordes, D. L. Greiner, and A. A. Rossini. 1997. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation 64: 329-335.
26. Zheng, X. X., Y. Li, X. C. Li, P. Roy-Chaudhury, P. Nickerson, Y. Tian, M. H. Sayegh, and T. B. Strom. 1999. Blockade of CD40L/CD40 costimulatory pathway in a DST presensitization model of islet allograft leads to a state of Allo-Ag specific tolerance and permits subsequent engraftment of donor strain islet or heart allografts. Transplant. Proc. 31: 627-628.
27. Parker, D. C., D. L. Greiner, N. E. Phillips, M. C. Appel, A. W. Steele, F. H. Durie, R. J. Noelle, J. P. Mordes, and A. A. Rossini. 1995. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. Natl. Acad. Sci. USA 92: 9560-9564.
28. Gordon, E. J., T. G. Markees, N. E. Phillips, R. J. Noelle, L. D. Shultz, J. P. Mordes, A. A. Rossini, and D. L. Greiner. 1998. Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti-CD154 monoclonal antibody. Diabetes 47: 1199-1206.
29. Elster, E. A., H. Xu, D. K. Tadaki, S. Montgomery, L. C. Burkly, S. D. Berning, R. E. Baumgartner, F. Cruzata, R. Marx, D. M. Harlan, et al. 2001. Treatment with the humanized CD154-specific monoclonalantibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates. Transplantation 72: 1473-1478.
30. + T cells and prolonged graft survival in a CTLA4-dependent manner. J. Immunol. 164: 512-521.
31. Quazada, S. A., B. Fuller, L. Z. Jarvinen, M. Gonzalez, B. R. Blazar, A. Y. Rudensky, T. B. Strom, and R. J. Noelle. 2003. Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation. Blood 102: 1920-1926.
32. Sanchez-Fueyo, A., C. Domenig, T. B. Strom, and X. X. Zheng. 2002. The complement dependent cytotoxicity (CDC) immune effector mechanism contributes to anti-CD154 induced immunosuppression. Transplantation 74: 898-900.
33. Monk, N. J., R. E. Hargreaves, J. E. Marsh, C. A. Farrar, S. H. Sacks, M. Millrain, E. Simpson, J. Dyson, and S. Jurcevic. 2003. Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade. Nat. Med. 9: 1275-1280.
34. Qiodera, K., A. Chandraker, M. Schaub, T. H. Stadlbauer, S. Korom, R. Peach, P. S. Linsley, M. H. Sayegh, and J. W. Kupiec-Weglinski. 1997. CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses. J. Immunol. 159: 1711-1717.
35. Wekerle, T., J. Kurtz, S. Bigenzahn, Y. Takeuchi, and M. Sykes. 2002. Mechanisms of transplant tolerance induction using costimulatory blockade. Curr. Opin. Immunol. 14: 592-600.
36. Crubin, C. E., S. Kovats, P. deRoos, and A. Y. Rudensky. 1997. Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class E-bound self-peptides. Immunity 1: 197-208.
37. Billingham, R. E., L. Brent, and P. B. Medawar. 1953. Activity acquired tolerance of foreign cells. Nature 172: 603-606.
38. + T cell tolerance and linked suppression. J. Immunol. 163: 4805-4810.
39. + T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J. Immunol. 169: 5401-5404.
40. Jones, N. D., S. E. Turvey, A. Van Maurik, M. Hara, C. I. Kingsley, C. H. Smith, A. L. Mellor, P. J. Morris, and K. J. Wood. 2001. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J. Immunol. 166: 2824-2830.
41. Nocentini, G., L. Giunchi, S. Ronchetti, L. T. Krausz, A. Bartoli, R. Moraca, G. Migliorati, and C. Riccardi. 1997. A new member of the tumor necrosis factor/ nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc. Natl. Acad. Sci. USA 94: 6216-6221.
42. Kwon, B., K. Y. Yu, J. Ni, G. L. Yu, I. K. Jang, Y. J. Kim, L. Xing, D. Liu, S. X. Wang, and B. S. Kwon. 1999. Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand. J. Biol. Chem. 274: 6056-6061.
43. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16: 311-323.
44. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3: 135-142.
45. Tone, M., Y. Tone, E. Adams, S. F. Yates, M. R. Frewin, S. P. Cobbold, and H. Waldmann. 2003. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc. Natl. Acad. Sci. USA 100: 15059-15064.
46. + T cell activation and experimental autoimmune encephalomyelitis. J. Immunol. 172: 4686-4690.
47. Ronchetti, S., O. Zollo, S. Bruscoli, M. Agostini, R. Bianchini, G. Nocentini, E. Ayroldi, and C. Riccardi. 2004. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur. J. Immunol. 34: 613-622.
48. + T cells. J. Immunol. 173: 5008-5020.
49. Graca, L., K. Honey, E. Adams, S. P. Cobbold, and H. Waldmann. 2000. Cutting edge: anti-CD154 therapeutic antibodies induce infectious transplantation tolerance. J. Immunol. 165: 4783-4786.
50. Foy, T. M., J. D. Laman, J. A. Ledbetter, A. Aruffo, E. Claassen, and R. J. Noelle. 1994. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180: 157-163.
51. +T cells. Immunity 19: 877-889.
52. Morecki, S., B. Leshem, M. Weigensberg, S. Bar, and S. Slavin. 1985. Functional clonal deletion versus active suppression in transplantation tolerance induced by total-lymphoid irradiation. Transplantation 40: 201-210.
53. Zheng, X. X., A. Sanchez-Fueyo, C. Domenig, and T. B. Strom. 2003. The balance of deletion and regulation in allograft tolerance. Immunol. Rev. 196: 75-84.
54. + cells, and the alloreactive T cell clone size. J. Immunol. 169: 3744-3751.
55. Slavin, S., S. Morecki, M. Weigensberg, S. Bar, and L. Weiss. 1986. Functional clonal deletion versus suppressor cell-induced transplantation tolerance in chimeras prepared with a short course of total-lymphoid irradiation. Transplantation 41: 680-687.
56. Wells, A. D., X. C. Li, Y. Li, M. C. Walsh, X. X. Zheng, Z. Wu, G. Nunez, A. Tang, M. Sayegh, W. W. Hancock, et al. 1999. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat. Med. 5: 1303-1307.
57. Gruchalla, R. S., and J. W. Streilein. 1981. Transplantation tolerance: clonal deletion, active suppression, or both? Transplant. Proc. 13: 574-577.
58. + regulatory T cells. Int. Immunol. 16: 1189-1201.
59. Tang, Q., K. J. Henriksen, M. Bi, E. B. Finger, G. Szot, J. Ye, E. L. Masteller, H. McDevitt, M. Bonyhadi, and J. A. Bluestone. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes J. Exp. Med. 199: 1455-1465.
60. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199: 1467-1477.